convatec logo

Tehnologija Hydrofiber®

Kako deluje Hydrofiber®:

convatec hydrofiber obloga scaled

1. Geliranje obloge

  • Hydrofiber® tehnologija vsebuje mehak, vpojen material, ki se v stiku z izločkom iz rane spremeni v gel.
  • Nastali gel ustvari optimalno okolje za celjenje ran.*1,6,10,11,13
hydrofiber bakterije scaled

2. Zaklene izloček in bakterije

  • Pomaga pri zaščiti kože okoli rane in zmanjša maceracijo.4,5
  • Pripomore k zmanjšanju možnost okužbe pri menjavi.6,7
hydrofiber obloge za rane

3. Popolnoma se prilagodi rani

  • Minimalizira “mrtvi prostor”, kjer se lahko razmnožujejo bakterije.8
  • Ohranja optimalno vlažno okolje za celjenje ran.9

Prikaz delovanja Hydrofiber®:

convatec hydrofiber 1 scaled

Največkrat uporabljena obloga:

Aquacel Ag+ Extra™

Aquacel Ag Extra

Dve tehnologiji v enem:

Hydrofiber®

Pripomore k nastanku optimalnih pogojev za celjenje ran in delovanju Ag+ Tehnologije.

  • ZAKLENE odvečen izloček, bakterije in biofilm, s čimer minimalizira
    možnost okužbe in prepreči maceracijo.*2.4-2.7, 2.10, 2.11
  • POPOLNOMA SE PRILAGODI rani, ohranja optimalno razmerje vlage in prepreči nastanek praznega prostora, na katerem bi lahko nastal biofilm ali se razmnožile bakterije.*2.12, 2.13
  • REAGIRA na stanje rane, saj tvori kohezivni gel in omili bolečino, ki se sicer pojavi ob menjavi obloge.
hydrofiber tehnologija
more than silver

More than silver®

Edinstvena formulacija z vsebnostjo srebra, ki deluje proti biofilmu tako, da:*2.1-2.3

  • TOPI in razbije zaščitno sluz biofilma in tako popolnoma razkrije bakterije.*2.1-2.3
  • UNIČI širok spekter bakterij, zahvaljujoč srebru, tudi tiste, ki so sicer
    odporne na antibiotike.*2.2, 2.3, 2.9
  • PREPREČI ponoven nastanek biofilma.*2.2, 2.3

99 % vprašanih zdravstvenih strokovnjakov bi priporočilo uporabo obloge AQUACEL® Ag+ Extra™.3.1

Ostali artikli s tehnologijo Hydrofiber®:

Reference

Reference za tehnologijo Hydrofiber®:

*Testirano in vitro

1. Waring MJ, Parsons D. Physico-chemical characterisation of carboxymethylated spun cellulose fibres. Biomaterials. 2001;22:903-912.

2. Walker M, Hobot JA, Newman GR, Bowler PG. Scanning electron microscopic examination of bacterial immobilisation in a carboxymethylcellulose (Aquacel) and alginate dressings. Biomaterials. 2003;24(5):883.-890.

3. Newman GR, Walker M, Hobot J, Bowler P. Visualisation of bacterial sequestration and bactericidal activity within hydrating Hydrofiber® wound dressings. Biomaterials. 2006;27:1129-1139.

4. Coutts P, Sibbald RG. The effect of a silvercontaining Hydrofiber dressing on superficial wound bed and bacterial balance of chronic wounds. Int Wound J. 2005;2(4):348-356.

5. Robinson BJ. The use of a hydrofiber dressing in wound management. J Wound Care. 2000;9(1):32-34.

6. Walker M, Hobot JA, Newman GR, Bowler PG. Scanning electron microscopic examination of bacterial immobilisation in a carboxymethylcellulose (Aquacel) and alginate dressings. Biomaterials. 2003;24(5):883.-890.

7. Bowler PG, Jones SA, Davies BJ, Coyle E. Infection control properties of some wound dressings. J. Wound Care. 1999;8(10):499-502.

8. Jones S, Bowler PG, Walker M. Antimicrobial activity of silver-containing dressings is influenced by dressing conformability with a wound surface. WOUNDS. 2005;17(9):263-270.

9. Bishop SM, Walker M, Rogers AA, Chen WYJ. Moisture balance: optimising the wound-dressing interface. J Wound Care. 2003;12:125-128.

10. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber® dressing. Wound Rep.Regen. 2004;12: 288-294.

11. Bowler PG, Jones SA, Walker M, Parsons D. Microbicidal properties of a silver-containing Hydrofiber® dressing against a variety of burn wound pathogens. J.Burn Care Rehabil. 2004;25: 192-196.

12. Bowler PG. Progression towards healing: wound infection and the role of an advanced silver-containing Hydrofiber® dressing. Ostomy Wound Manage. 2003;49:(8) (suppl):S2-S5.

13. Walker M, Bowler PG, Cochrane CA. In vitro studies to show sequestration of matrix metalloproteinases by sliver-containing wound care products. Ostomy Wound Manag. 2007;53(9):18-25.

Reference za Aquacel Ag+ Extra 2.1.Physical Disruption of Biofilm by AQUACEL® Ag+ Wound Dressing. Scientific Background Report. WHRI3850 MA232, 2013, Data on file, ConvaTec Inc. 2.2. Antimicrobial activity and prevention of biofilm reformation by AQUACEL™ Ag+ EXTRA dressing. Scientific Background Report. WHRI3857 MA236, 2013, Data on file, ConvaTec Inc. 2.3. Antimicrobial activity against CA-MRSA and prevention of biofilm reformation by AQUACEL™ Ag+ EXTRA dressing. Scientific Background Report. WHRI3875 MA239, 2013, Data on file, ConvaTec Inc. 2.4. Newman GR, Walker M, Hobot JA, Bowler PG, 2006. Visualisation of bacterial sequestration and bacterial activity within hydrating Hydrober™ wound dressings. Biomaterials; 27: 1129-1139. 2.5. Walker M, Hobot JA, Newman GR, Bowler PG, 2003. Scanning electron microscopic examination of bacterial immobilization in a carboxymethyl cellulose AQUACEL™) and alginate dressing. Biomaterials; 24: 883-890. 2.6. Bowler PG, Jones SA, Davies BJ, Coyle E, 1999. Infection control properties of some wound dressings. J. Wound Care; 8: 499-502. 2.7. Walker M, Bowler PG, Cochrane CA, 2007. In vitro studies to show sequestration of matrix metalloproteinases by silver-containing wound care products. Ostomy/Wound Management. 2007; 53: 18-25. 2.8. Assessment of the in vitro Physical Properties of AQUACEL EXTRA, AQUACEL Ag EXTRA and AQUACEL Ag+ EXTRA dressings. Scientific background report. WHRIA3817 TA297, 2013, Data on file, ConvaTec Inc. 2.9. Bowler PG, Welsby S, Towers V, Booth V, Hogarth A, Rowlands V, Joseph A, et al, 2012. Multidrug-resistant organisms, wounds and topical antimicrobial protection. Int Wound J. 9: 387-396. 2.10. Walker M and Parsons D, 2010. Hydrofiber Technology: its role in exudate management. Wounds UK; 6: 31-38. 2.11. Parsons D, Bowler PG, Myles V, Jones SA, 2005. Silver antimicrobial dressings in wound management: A comparison of antibacterial, physical and chemical characteristics. WOUNDS; 17: 222-232. 2.12. Jones SA, Bowler PG, Walker M, 2005. Antimicrobial activity of silver-containing dressings is influenced by dressing conformability with a wound surface. WOUNDS; 17: 263-270. 2.13. Walker M, Jones S, Parsons D, Booth R, Cochrane C, Bowler P, 2011. Evaluation of low-adherent antimicrobial dressings. Wounds UK; 7: 32-45. 2.14. Barnea Y, Armir A, Leshem D, Zaretski A, Weiss J, Shafir R, et al, 2004. Clinical comparative study of Aquacel and paraffin gauze dressing for split-skin donor site treatment. Ann Plast Surg; 53: 132-136. 2.15. Kogan L, Moldavsky M, Szvalb S, Govrin-Yehudain J, 2004. Comparative study of Aquacel and Silverol treatment in burns. Ann Burns Fire Disasters; 17: 201-207. 2.16. Brunner U, Eberlein T, 2000. Experiences with hydrofibres in the moist treatment of chronic wounds, in particular of diabetic foot. VASA; 29: 253-257. 2.17. Assessment of the in vitro physical properties of AQUACEL Ag, AQUACEL Ag EXTRA and AQUACEL Ag+ Dressings, Scientific Background Report. WHRI3817 TA297, 2013, Data on file, ConvaTec Inc. 2.18. Harding K, Ivans N, Cains J, An opened randomized comparative study to evaluate the clinical and economic performance of two absorbent dressings in venus leg ulcers. Poster presented at EWMA; May 15-17 2013; Copenhagen, Denmark. 2.19. Parsons D, Mustoe T, Seth A. A new anti-biofilm Hydrofiber™ dressing: an in vivo investigation. Poster presented at Wounds UK; Nov 11-13 2013; Harrogate, UK.

3.1. Metcalf DG, Parsons D, Bowler PG. Clinical safety and effectiveness evaluation of a new antimicrobial wound dressing designed to manage exudate, infection and biofilm. Int Wound J. 2017

convatec tagline v2

Imate vprašanje o izdelkih Convatec?

PIŠITE NAM